April 23, 2018 7:40 PM ET

Healthcare Equipment and Supplies

Company Overview of Mega Elektroniikka Oy

Company Overview

Mega Elektroniikka Oy, a medical technology company, provides biosignal monitoring solutions for cardiology, neurology, rehabilitation, occupational health, and sports medicine. It offers eMotion Biolink, a wireless system for measuring and monitoring biosignals, such as EMG, ECG, heart rate variability (HRV), and EEG; eMotion ECG Mobile, a remote electrocardiography (ECG) monitoring system; eMotion Faros, a device for monitoring ECG, HRV, stress, recovery, and general well-being; HRV Scanner, a heart rate variability analyzing system for occupational health and rehabilitation; and FemiScan therapy, pain-free method for the treatment of urinary incontinence and pelvic floor rehabilitation. T...

Pioneerinkatu 6

Kuopio,  70800


Founded in 1983


358 4050 52417


358 1758 00978

Key Executives for Mega Elektroniikka Oy

Compensation as of Fiscal Year 2017.

Mega Elektroniikka Oy Key Developments

Bittium Biosignals Ltd Signs Supply Agreement to Deliver Customized ECG Monitoring Devices

Bittium Biosignals Ltd. has signed a supply agreement to deliver customized ECG monitoring devices to a major US remote monitoring company. Bittium Biosignals Ltd. and a major US remote monitoring provider, have concluded a three-year supply agreement under which Bittium will supply the Bittium FarosTM 360 and customized Bittium FarosTM 360 cardiac ECG signal measuring and monitoring devices. In addition, Bittium will supply disposable electrodes for attaching Bittium Faros ECG devices. The agreement, including product customization work, contains terms and conditions that are typical for supply agreements such as schedule and quality requirements. In addition the agreement enables development cooperation between the parties. The Bittium Faros 360 has U.S. FDA regulatory approval and according to the agreement Bittium is responsible for FDA approval of the customized Bittium Faros 360 device. The agreement terms include exclusive distribution rights for the Bittium Faros 360 devices for ambulatory ECG monitoring services in the U.S.A. The Bittium Faros 360 is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. The Bittium Faros is ultra-small and lightweight and enables precise, long-term full disclosure ECG measurements and recordings, monitoring abnormal cardiac events, and mobile cardiac telemetry.

Similar Private Companies By Industry

Company Name Region
Addoz Oy Europe
Ani Biotech Oy Europe
Biofile Ltd Europe
Bioretec Oy Europe
BonAlive Biomaterials Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mega Elektroniikka Oy, please visit www.megaemg.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.